In addition to Epo treatments widely used to generate an adequate burst of early erythroid cells in patients with various anemia-causing conditions, one should thus also consider targeting Sox6 to ensure timely maturation and release, as well as long life of newly generated red blood cells. This evidence concerns the gene SOX6 and anemia.